Globeflex Capital’s Champions Oncology CSBR Stock Holding History

Globeflex Capital’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,564	Closed	-$35K	–	469
2023 Q2	$35K	Sell	5,564 -2,985	-35%	-$15.4K	﹤0.01%	420
2023 Q1	$34.4K	Hold	8,549	–	–	﹤0.01%	429
2022 Q4	$38.6K	Hold	8,549	–	–	﹤0.01%	431
2022 Q3	$64K	Hold	8,549	–	–	0.01%	435
2022 Q2	$69K	Hold	8,549	–	–	0.02%	417
2022 Q1	$70K	Hold	8,549	–	–	0.01%	415
2021 Q4	$68K	Hold	8,549	–	–	0.01%	406
2021 Q3	$87K	Hold	8,549	–	–	0.02%	395
2021 Q2	$88K	Hold	8,549	–	–	0.02%	412
2021 Q1	$97K	Hold	8,549	–	–	0.02%	414
2020 Q4	$92K	Sell	8,549 -24,892	-74%	-$257K	0.02%	422
2020 Q3	$309K	Sell	33,441 -3,092	-8%	-$27.5K	0.08%	326
2020 Q2	$349K	Buy	36,533 +13,245	+57%	+$113K	0.09%	338
2020 Q1	$172K	Buy	+23,288	New	+$163K	0.05%	379

Other funds holding CSBR

BMC

Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Globeflex Capital's CSBR Position: Q3 2023 in Review

Globeflex Capital sold out of Champions Oncology (CSBR) in Q3 2023, closing a stake of 5,564 shares — an estimated $35K sold.

Globeflex Capital first reported a position in CSBR in Q1 2020 and held it in 14 quarters. The position peaked at $349K in Q2 2020. 29 funds tracked by Wall St. Rank hold CSBR as of Q3 2023.

Globeflex Capital reported no remaining Champions Oncology position as of Q3 2023 after selling out during the quarter.
Globeflex Capital sold 5,564 Champions Oncology shares in Q3 2023, an estimated $35K.
Globeflex Capital first reported a position in Champions Oncology in Q1 2020 and held it in 14 quarters.
Globeflex Capital's Champions Oncology position peaked at $349K in Q2 2020.
29 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2023.

Based on Globeflex Capital's 13F filing for Q3 2023, filed 13 Nov 2023.